Related Experiment Video
Updated: Nov 25, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Tumor Necrosis Factor Receptors: Pleiotropic Signaling Complexes and Their Differential Effects
1Epithelial Therapeutics Unit, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, United States.
Abstract:
Since its discovery in 1975, TNFα has been a subject of intense study as it plays significant roles in both immunity and cancer. Such attention is well deserved as TNFα is unique in its engagement of pleiotropic signaling via its two receptors: TNFR1 and TNFR2. Extensive research has yielded mechanistic insights into how a single cytokine can provoke a disparate range of cellular responses, from proliferation and survival to apoptosis and necrosis. Understanding the intracellular signaling pathways induced by this single cytokine via its two receptors is key to further revelation of its exact functions in the many disease states and immune responses in which it plays a role. In this review, we describe the signaling complexes formed by TNFR1 and TNFR2 that lead to each potential cellular response, namely, canonical and non-canonical NF-κB activation, apoptosis and necrosis. This is followed by a discussion of data from in vivo mouse and human studies to examine the differential impacts of TNFR1 versus TNFR2 signaling.
Insights
Tumor Necrosis Factor-alpha (TNFα) signals through TNFR1 and TNFR2 receptors, triggering diverse cellular responses like apoptosis and NF-κB activation. This review details these pathways and their in vivo implications in immunity and cancer.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Biology
Background:
- Tumor Necrosis Factor-alpha (TNFα), discovered in 1975, is crucial in immunity and cancer.
- TNFα exhibits pleiotropic signaling through its receptors, TNFR1 and TNFR2.
- Understanding TNFα's diverse cellular effects (proliferation, survival, apoptosis, necrosis) is vital for disease research.
Purpose of the Study:
- To elucidate the intracellular signaling pathways initiated by TNFα via TNFR1 and TNFR2.
- To detail the distinct signaling complexes leading to canonical/non-canonical NF-κB activation, apoptosis, and necrosis.
- To analyze in vivo data from mouse and human studies on TNFR1 versus TNFR2 signaling impacts.
Main Methods:
- Review of existing literature on TNFα signaling pathways.
- Analysis of signaling complexes formed by TNFR1 and TNFR2.
- Examination of in vivo studies investigating TNFR1 and TNFR2 functions.
Main Results:
- Detailed description of signaling complexes mediating cellular responses.
- Explanation of canonical and non-canonical NF-κB activation pathways.
- Discussion of differential roles of TNFR1 and TNFR2 signaling in vivo.
Conclusions:
- TNFα's dual receptor engagement dictates varied cellular outcomes.
- Intracellular signaling mechanisms are key to understanding TNFα's role in disease.
- Further research into TNFR1/TNFR2 differential signaling is warranted for therapeutic insights.
More Related Videos
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
09:51Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Receptor Tyrosine Kinases